In England and Wales 4% of cancer deaths are due to carcinoma of the cervix. There are approximately 4,000 new cases of invasive cervical carcinoma per annum, with an overall mortality of 50% (OPCS, 1990a) . Whilst the total number of deaths has fallen slightly, there has been a significant increase in cervical cancer incidence and mortality in women under the age of 45. In 1974 45. In -1978 there were 692 deaths from cervical cancer in these younger women. In the next 5 years, 1979-1983 , the number had increased to 986, with 1,203 deaths 1984 986, with 1,203 deaths -1988 986, with 1,203 deaths (OPCS, 1977 986, with 1,203 deaths -1990b . During the same period deaths in older women fell from 9,607 in 1974-1978 to 8,595 in 1979-1984 to 7,860 in 1984 7,860 in -1988 7,860 in (OPCS, 1977 7,860 in -1990b . A similar trend has been reported from elsewhere. In Australia, for example, the proportion of women under 35 with cervical cancer increased from under 9% of cases in the 1950's, to 25% in the 1970's and 1980's (Elliott et al., 1989) .
Squamous carcinoma is the commonest carcinoma of the cervix (Anderson, 1985) , although if mucin stains are used, up to 30% are shown to be adenosquamous (Buckley & Fox, 1989) . In most cases there appears to be a progression from mild cervical intra-epithelial neoplasia (CIN 1), through moderate (CIN 2), to severe dysplasia/carcinoma-in situ (CIN 3) before frank invasive carcinoma supervenes (Reagan et al., 1953; Richart, 1967; Buckley et al., 1982) . In a small number of women, the diagnosis of invasive tumour is made soon after a previous negative smear, with no detectable transition stage (Ashley, 1966; Hakama & Penttinen, 1981; Peters et al., 1988) . The cytological characteristics of the cells involved in CIN 3 as well as those in invasive carcinoma are those of a malignant phenotype, and show pleomorphism, loss of polarity, abnormal mitotic figures and aneuploidy. The cells of invasive carcinoma have the ability to transgress the basement membrane, spread locally and metastasise, with a resulting 50% mortality (OPCS, 1990b) . The cells of in situ carcinoma have not transgressed the basement membrane and may lack factors that would enable them to do so.
In order to study differences between normal, dysplastic and invasive malignant cervical epithelial cells we have established such cells in monolayer culture and as xenografts in nude mice. In Minor modifications of methods previously published were used to establish the cell line (Stanley & Parkinson, 1979; Stanley & Dahlenburg, 1984 (ICN Flow) , and 10 ng ml' cholera toxin (Sigma).
At passage #4 a colony consisting predominantly of small rapidly dividing epithelial cells was selected and passaged further. Fibroblasts from the cervical stroma were removed by incubation with 0.02% EDTA in EBSS at 37°C for 2-3 min and then vigorous pipetting against the surface of the flask (Stanley & Parkinson, 1979) . The 3T3 feeder layer was omitted from passage #6 onwards (>>300 population doublings).
A Mycotect kit (Gibco) was used to test for Mycoplasma infection at 3-4 week intervals.
XHJa and XHlb sublines At passage #29 XH1 single cells were plated in enriched medium at densities of 5-100 cells/well in 24-well plates on Mitomycin-C treated 3T3 cells. Growth was only seen in wells seeded with 50-100 cells/well. After passage #4, 3T3 feeder cells were no longer required. Two sublines of cells emerged with differing cell morphologies (see Results). One of each type was selected, designated XHla and XHlb. They were subjected to more than 80 further passages.
Karyotyping
Chromosome preparations from XHI cells passage #6 were made by standard methods using colcemid for 1-2 h at a final concentration of 0.02p1gmlm' and hypotonic KCI/ EDTA for 20 min (Seizinger et al., 1987) . Chromosomes from 30 metaphases were counted on aceto-orcein stained slides, and 13 cells from G-banded preparations were analysed in full from photographs.
Hypervariable minisatellite DNA probing Locus-specific hypervariable minisatellite probes, MS1 and MS31 (ICI Biological Products, Cheshire) (Wong et al., 1987; were used to ensure that the XH1 cells were not contaminated with the established cell lines Caski (Patillo et al., 1977) , A431 (Giard et al., 1973) and Bowes melanoma (Rifkin et al., 1974) , also maintained in this laboratory.
DNA was isolated from the patient's blood and cultured cells by proteinase K (50 mg ml) (Boehringer Corporation London Ltd, BCL, Sussex) and phenol-chloroform extraction (Sambrook et al., 1989) . Ten jig DNA was digested with HinJI (BCL) and electrophoresed in a 0.7% agarose gel until fragments smaller than 2 kb had run off the gel. After electrophoresis, the DNA fragments were denatured, transferred to Hybond-N (Amersham International plc, Bucks), and hybridised with MS31 labelled with digoxigenin by random hexanucleotide priming, according to the manufacturer's instructions (BCL) (Feinberg & Vogelstein, 1983) . Though HeLa cells (Gey et al., 1952) have not been grown in this laboratory, HeLa DNA (obtained from Dr Farrell, Ludwig Institute, London) was also probed to exclude contamination of the other cell lines with HeLa. Because the bands obtained using A431 and Caski ran in a similar position, DNA from these cell lines and from XH1 and Bowes melanoma was also probed with digoxigenin-labelled MS1.
DNA preparation for HPV analysis Total cellular DNA was purified by lysing the cells in 10 mM Tris-Cl (pH 8) -10 mM NaCl -10 mM EDTA (pH 8) -0.5% SDS containing 100 pgml-' proteinase K and incubation overnight at 37°C. Proteins were removed by sequential extractions with equal volumes of phenol, phenol-chloroform-isoamyl alcohol (25:24:1) and chloroform-isoamyl alcohol (24:1). RNA was then removed by treatment with 501ag ml-' RNAase A, followed by digestion with 100 lgml-' proteinase K in 1% SDS and deproteination as above. DNA was precipitated with ethanol, resuspended in water and the concentration determined by spectrophotometry. Human placental DNA was used as a negative control to confirm the absence of false positives in the PCR reactions.
Hybridisation analysis
Total cellular DNA in 10 lg aliquots either undigested or each digested with BamHI, HindIII or PstI, were each electrophoresed through 0.8% agarose gels in TAE buffer. After electrophoresis DNA samples were prepared and transferred to nylon membranes (HyBond-N, Amersham, Bucks) using a Posiblotter (Stratagene, NBL, Northumberland) under the conditions described by the manufacturers. A random primer labelling technique (MultiPrime, Amersham) was used to generate 32P-labelled HPV16 probes. These probes were used to challenge membrane bound DNA samples in 5 x SSC -5 x Denhardts -0.5% SDS -100 gml-' denatured, sheared salmon sperm DNA at (Tm-20'C) for 16 h. They were washed first at low stringency (Tm.40TC) then at high stringency (Tm-IO0C). Kilobase ladder DNA markers (BRL, Paisley) were used to determine the size of the PGR product.
Culture in soft agar XHIa or XHlb cells were mixed with 0.5% agar solution (Agar Noble, Difco Laboratories, Surrey) in enriched medium to give a final agar concentration of 0.35%, and a cell density 5 x I04ml-'. After 4 weeks the agar was decanted and colonies containing more than 50 cells were counted.
Xenografts
Xenograft production was attempted in 53 nude mice (athymic nu/nu on Balb/c background). Twelve were female, 41 were male and they ranged in age from 3-20 weeks. Single cell suspensions in PBS pH 7.2 of various passages of XH1, XHIa, XHlb cells, and a xenograft obtained by inoculation of passage #5 of XH1 cells, were used. Five x 106 cells were injected subcutaneously into both pectoral regions of 43 mice, and 107 cells were also injected intraperitoneally into three of these mice. 1-5 x I04 cells were injected into the tail vein of 22 mice, 12 of which also had simultaneous bilateral subcutaneous inoculation. Eight mice died immediately after intravenous injection, and four more died unexpectedly. Mice bearing XH1 or XH 1 a xenografts were sacrificed either when the subcutaneous tumours reached 1.5-2 cm in maximum diameter, or seemed about to ulcerate. Mice bearing XH1b xenografts were sacrificed at 5 and 7 days and thereafter at weekly intervals up to 50 days.
Immunocytochemistry Formalin-fixed paraffin-embedded sections of the primary tumour, pellets of XHI, XHIa and XHlb cells (Heyderman et al., 1989) , and sections of xenografts were stained with a variety of antibodies. Monoclonal antibodies to epithelial membrane antigen (EMA) (Heyderman et al., 1979) , carcinoembryonic antigen (CEA), low molecular weight cytokeratin (CAM 5.2 antibody), desmin and vimentip, and a rabbit polyclonal antibody to S100 were used (See Table I for sources and positive control tissues). They were also stained with TDM35 a murine monoclonal antibody raised against XH1 cells (Han et al., 1990 ). An ABC method without enzyme predigestion (Hsu et al., 1981) as employed using a biotinylated anti-species secondary antibody and streptavidin/biotin complex (Dako, Bucks). Endogenous peroxidase was inhibited by a sequence of hydrogen peroxide, (Heyderman, 1986 ).
Negative controls
The relevant antigens for the antibodies used in this study were not available to perform specificity controls using antibody absorbed with the corresponding antigen (Heyderman et al., 1989 (Figure 3 ). There were a number of chromosome rearrangements whose probable origin could be determined. These were 4p+, 5q-, lOp+, llp+, Ilp-, llq+, l2p-, 14p+, 14q+, and l5p+, and there were several markers of unknown origin (Figure 4) ;g' m2 ml-m3 ii "I and PstI sites characterstics of HPV16 (Seedorf et al., 1985) ( Figure 8 Xenograft results (Table II) XHI and XHJa Nodules of subcutaneous tumou palpable 5-21 days after inoculation, and formi 1.5cm in diameter in 21-158 days. There was c( variation in the growth rate and size of the tumour xenografts. The time the tumours took to reach 1.5 cm was independent of the passage number, or the sex or age of the mice.
Tumours derived from XH1 and XH1a cells showed an adenosquamous morphology similar to that of the original cervical carcinoma (Figures 9 and 10 ). Desmosomes and -451 tonofilaments were seen at EM level (Figure 11 and 12 ).
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There was a variable amount of central necrosis, present sometimes in tumours less than 1 cm in maximum diameter as well as in some of the larger xenografts. There was focal glandular differentiation, and as in the primary tumour, epithelial mucin was demonstrable. The xenografts could be passaged from one mouse to another by inoculation of fresh fragments, and the passaged xenografts continued to show the same morphology. In the three mice inoculated intra-7) and (13) peritoneally and subcutaneously, tumour was seen at both ith BamHI; sites. i), (11) (Figure 18 ). XHlb cell pellets and xenografts were negative for TDM35. All of the tumours and cell pellets were abundant desmosomes. the cells were seen to be degenerating and pyknotic ( Figure  16 ). In nodules removed after 10-12 days, the tumours were seen to have regressed completely or undergone cystic degeneration, with the cyst wall consisting of loose vascular fibrous tissue. No tumour cells could be identified on H&E or immunostains. After 28 days no tumour was palpable and sections of the site showed cellular connective tissue and confirmed the absence of tumour. Figure negative for S100 and desmin. Perineural spread and invasion by xenografts into the host muscle was highlighted using antibodies to S100 and desmin, for which the tumours were themselves negative.
Local invasion

Discussion
In this paper data on the establishment and characterisation of XH1, a new cervical carcinoma cell line derived from an adenosquamous carcinoma is presented. (Auersperg, 1969; Auersperg et al., 1989) . A similar divergence into different morphological types was produced in a murine bladder carcinoma cell line by changing the culture conditions (Boyer et al., 1989) . It is important to exclude contamination of new cell lines with HeLa or other established cell lines (Fogh et al., 1977a) . The hypervariable minisatellite probes MS1 and MS31 were used to show that DNA from XH1 and its sublines was like that extracted from the patient's white blood cells, and different from DNA from A431, Caski, Bowes melanoma, HeLa and mouse fibroblast 3T3 cells.
The karyotype of cultured tumour cells may undergo considerable changes in vitro and there is some evidence of chromosomal instability in XH1. However, since the culture was examined quite early on at passage #6, it is likely that many of the markers found were present in the original tumour. XH1 has a karyotype similar to other cervical carcinomas with many rearranged chromosomes. The small metacentric chromosome thought to be a 5q-is similar to markers found in 75% of direct preparations from primary cervical carcinomas (Atkin et al., 1990) . The marker M3 in XH1 may represent a similar rearrangement. No normal copies of chromosome 11 were found in XH1 indicating that several rearrangements have occurred in this chromosome. Since the HeLa tumour suppressor gene has been localised to the long arm of chromosome 11 (Misra & Srivatsan, 1989) , in vivo changes at this region might result in loss of llq sequences that could be important in tumourigenesis. The XH1 sublines are being cloned by single cell selection and the karyotype differences between them will be investigated.
Several squamous cervical carcinoma cell lines have previously been reported. Some were derived from primary cervical carcinomas, including HeLa, Cl, C4 I and II, C12, C33 I and II, OG, SiHa, SW756, SKG, SKG-1, SKG-2 and SKG-III, Yumoto strain, HX151c, 155c, 156c and 160c (Gey et al., 1952; Auersperg & Hawryluk, 1962; Auersperg, 1964; Auersperg, 1969; Arata et al., 1969; Friedl et al., 1970; Freedman et al., 1982; Nozawa et al., 1978; Ishiwata et al., 1978; Yokita et al., 1980; Nozawa et al., 1982; Nozawa et al., 1983; Kelland et al., 1987) . Others were derived from secondary deposits. These include CaSki, ME-180, MS751, HT-3, EC50 and DoT (Sykes et al., 1970; Fogh & Trempe, 1975; Patillo et al., 1977; Hussa et al., 1978; Porter et al., 1978) . The W12 cell line was established from a CIN 1 cervical lesion (Stanley et al., 1989) . C4 I and II were classified as squamous carcinomas but showed mucin production (Auersperg, 1969) , and the SKG-2 cell line also contained PASpositive diastase resistant material (Ishiwata et al., 1978) . These cell lines should therefore be reclassified as adenosquamous (Buckley & Fox, 1989) . Although originally considered an epidermoid carcinoma, the HeLa cell line was later shown to have been derived from a cervical adenocarcinoma (Jones et al., 1971) .
Production of xenografts in nude mice using the cervical carcinoma cell lines C4 I, C33, HT-3, ME-180, MS751 and SW732 was reported in a large study, but no details of local invasion were given, and none metastasised spontaneously (Fogh et al., 1977b) . Other subcutaneous cervical carcinoma xenografts produced in nude mice include the SW756 (Porter et al., 1978) , SKG-1 and SKG-2 (Ishiwata et al., 1978; Nozawa et al., 1982) , and the HX15lc, HX155c, HX156c and HX160c cell lines (Kelland et al., 1987) . None of these metastasised, and generally host invasion was not commented upon, though stromal invasion was noted in the HX cell lines (Kelland et al., 1987) . Marked cachexia was seen in mice bearing Yumoto xenografts and 80% of them died within 3 months, but none of the tumours metastasised. These authors also produced Hela subcutaneous xenografts, some of which mnetastasised spontaneously to the lungs (Yokita et al., 1980) .
In an experiment on the human patient from whom the OG cell line was derived, inoculation of both OG and HeLa into the thigh at the time of tumour recurrence elsewhere resulted in initial growth and then the tumours regressed (Arata et al., 1969) . Growth of a subcutaneous xenograft of W12 cells derived at a site prepared by previous implantation of a glass coverslip has also been described (Stanley et al., 1989) . Local invasion did not occur (Stanley, Personal communication) .
The XH1 and XHIa xenografts are good models of local invasion. XH1 and XH1a cells will colonise the lungs after intravenous injection, but although vascular invasion was seen, none of the subcutaneous tumours had metastasised spontaneously. As the xenografts often threaten to ulcerate the overlying skin when they are less than 1 cm in diameter, experiments have to be terminated at this stage, which may be too early for metastasis. We intend removing primary subcutaneous xenografts when they are 0.75 cm in diameter, by which time micrometastasis could have occurred. The mice could then be maintained long enough for these metastatic cells to become established and detectable (Ueyama et al., 1978) .
The original cervical tumour from which XHI was derived, xenografts and cell pellets of XHI, XHIa and XHlb were positive for EMA and low molecular weight cytokeratin (CAM 5.2), consistent with their epithelial origin. They were also focally positive for vimentin. Co-expression of vimentin has been reported in a variety of epithelial neoplasms and is no longer considered to imply mesenchymal origin (Dabbs & Geisinger, 1988; Raymond & Leong, 1989) . The primary cervical carcinoma, XH1 and XH1a xenografts and cell pellets were all positive for CEA and TDM35, which appears to recognise an NCA-like/CEA-like molecule (Von Kleist, 1972; Han et al., 1990) . The XHlb xenografts and pellets were negative for CEA and for TDM35. CEA is a member of the immunoglobulin supergene family, and thought to be involved in cell adhesion and thereby to increase metastatic potential (Hostetter et al., 1990) . Absence of CEA and of the antigen recognised by TDM35 may be factors militating against continued XHlb xenograft growth. Evidence that not all cells that arrest in the pulmonary vasculature continue to grow was shown by the presence of fibrous focally calcified nodules in lungs containing tumour colonies elsewhere.
There is a strong association between cervical carcinoma and human papillomavirus (HPV) (Zur Hausen & Schneider, 1977) . XH1 and its sublines contain integrated HPV16 as do the other cervical carcinoma cell lines SiHa, CaSki, HX151c, HX155c, HX156c and HX160c, while HeLa, ME180, MS751, C4 I and C4 II contain HPV18 DNA. CaSki may have integrated HPV18 as well as HPV16; C-33A and HT-3 have neither (Yee et al., 1985; Pater et al., 1985; Spence et al., 1988) . As both XHIa and XHlb contain HPV16 DNA, integration of HPV DNA does not explain their different morphology or xenograft behaviour. It has been suggested that patients whose cervical tumours evidence HPV integration have a better prognosis than those with HPV-negative tumours (Riou et al., 1990) . The patient from whom XH1 was derived died of the disease within a year of diagnosis.
The XHlb subline provides a promising model of tumour regression and/or non-T cell mediated rejection. Possible mechanisms to be investigated by us include expression of the normal rather than a mutant p53 gene (Lane & Benchimol, 1990) , lack of appropriate angiogenesis factors (Folkman & Klagsbrun, 1987) , absence of plasminogen activators (Larsson et al., 1987) or of other proteases such as collagenase IV (Liotta et al., 1980) . Nude mice are T cell but not natural killer (NK) cell deficient and possible increased susceptibility of XHlb cells to NK cells will also be examined (Richie, 1984 
